Observing the correlation between factors affecting the response of macular edema due to retinal vein occlusion to first dose of anti VEGF injectio

Not Applicable

• Conditions: Health Condition 1: H341- Central retinal artery occlusion

• Registration Number: CTRI/2019/10/021774
• Lead Sponsor: Dr Shivraj Tagare

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 November 2021

Recruitment & Eligibility

• Status: ot Yet Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Treatment naïve patients with RVO macular edema in any one eye, presenting to the outpatient department of the Retina Clinic at Aravind Eye Hospital, Pondicherry. Age above 18 years old.

Exclusion Criteria

Cases of RVO induced macular edema previously treated with intravitreal anti-VEGF bevacizumab injections, steroid injections or photocoagulation and macular edema due to any other cause. Patient opting for antiVEGF other than bevacizumab will be excluded from the study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1. Change in CRT/CMT recorded on an OCT. <br/ ><br> <br/ ><br>Timepoint: 1. Change in CRT/CMT recorded on an OCT after 1 month of intravitreal anti-VEGF injection <br/ ><br>

Secondary Outcome Measures

Name	Time	Method
1. Change in SRF at the fovea on an OCT. <br/ ><br>2. Betterment in visual acuity. <br/ ><br>3. Correlation of the above with systemic factors and duration of disease. <br/ ><br>Timepoint: 1. Change in SRF at the fovea on an OCT after 1 month of giving intravitreal anti VEGF injection. <br/ ><br>2. Correlation of the above with systemic factors and duration of disease. <br/ ><br>